- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous complaint about AstraZeneca-sponsored psychiatrist meetings. Panel upheld one breach: overnight accommodation for a 4.5-hour Coventry meeting was not justified (Clause 19.1).…
A PCT adviser challenged AstraZeneca’s Symbicort budget impact presentation to GP practice managers and meeting sponsorship. Panel found the audience and hospitality…
A sponsored athlete with diabetes spoke to parents at a hospital fun day and repeatedly praised Lantus. PMCPA held Sanofi-Aventis responsible and…
A hospital pharmacist complained about a Pliva email to a colleague chasing action after a discounts/generics meeting. Panel found Cystistat was a…
GPs alleged a professor’s mesalazine letter (P&G educational grant) was disguised promotion for Asacol. Panel found no promotion/disguised promotion, but ruled Clause…
A Tramacet e-ad compared NNTs but omitted the commonly used co-codamol 60/1000 NNT (2.2), making Tramacet look more favourable. Breach of Clauses…
PMCPA case AUTH/3006/12/17 (Director v Lilly) concerning clinical trial disclosure for Trulicity. Outcome: No breach; matter was outwith the scope of the…
At ESC Congress 2015, Mylan offered frozen yoghurt from its exhibition stand. The Panel ruled this went beyond subsistence hospitality (Clause 22.1)…
PMCPA case AUTH/2691/1/14: complaint about clinical trial disclosure for Cimiza. The matter was found to be outwith the scope of the ABPI…
Anonymous complaint about Takeda meeting sponsorship. PMCPA recorded the matter as outwith the scope of the ABPI Code, so no case report…
A GP said a Durogesic DTrans promotional email was unsolicited and misused the NHS net. Janssen said it was sent only to…
Complaint alleged Facebook/Twitter meeting adverts lacked sponsorship statements and reached the public. Panel initially found a Clause 22.4 breach for one Facebook…
Beacon was held responsible for a third-party agency’s promotional email about Episenta sent without proven prior consent. The Panel found the “opt-in”…
GSK ran RLS disease-awareness ads in GP journals pointing to a patient group website. The site later included content implying ropinirole was…
Roche/GSK challenged a competitor slide kit on Bonviva using FDA-review material. Panel found it disparaged Bonviva and misled readers by blurring FDA…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.